EP Patent

EP1723114B1 — Biphenyl compounds useful as muscarinic receptor antagonists

Assigned to Innoviva Inc · Expires 2008-05-14 · 18y expired

What this patent protects

This invention provides compounds of formula (I): wherein a, b, c, d, m, n, p, s, t, W, Ar1, R1, R2, R3, R4, R6, R7, and R8 are as defined in the specification. The compounds of formula (I) are muscarinic receptor antagonists. The invention also provides pharmaceutical compositio…

USPTO Abstract

This invention provides compounds of formula (I): wherein a, b, c, d, m, n, p, s, t, W, Ar1, R1, R2, R3, R4, R6, R7, and R8 are as defined in the specification. The compounds of formula (I) are muscarinic receptor antagonists. The invention also provides pharmaceutical compositions containing such compounds, processes and intermediates for preparing such compounds and methods of using such compounds to treat pulmonary disorders.

Drugs covered by this patent

Patent Metadata

Patent number
EP1723114B1
Jurisdiction
EP
Classification
—
Expires
2008-05-14
Drug substance claim
No
Drug product claim
No
Assignee
Innoviva Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.